Skip to main content
. 2021 Jun 16;16(6):e0252969. doi: 10.1371/journal.pone.0252969

Table 2. Numbers of participants at each visit.

NC MCI AD
Follow-up visits Non-aspirin users Aspirin users Non-aspirin users Aspirin users Non-aspirin users Aspirin users
Baseline 310 199 586 399 231 141
1 y 246 160 510 362 176 112
2 y 230 149 407 283 106 65
3 y 139 78 348 228 5 5
4 y 137 98 238 168 1 1
5 y 86 48 157 105 1 1
6 y 109 79 128 88 0 2
7 y 85 54 97 78 / /
8 y 68 46 69 49 / /
9 y 43 16 33 26 / /
10 y 29 17 17 11 / /
11 y 26 12 8 9 / /
12 y 20 8 7 7 / /
13 y 22 9 3 2 / /
14 y 5 3 1 0 / /

Abbreviations: CN: normal cognition; MCI: mild cognitive impairment; AD: Alzheimer’s disease.